| [1] |
El Hussein S, Medeiros LJ, Khoury JD. Aggressive NK cell leukemia: current state of the art[J]. Cancers (Basel), 2020, 12(10): 2900. DOI: 10.3390/cancers12102900.
doi: 10.3390/cancers12102900
|
| [2] |
Zheng J, Liu H, Chen Y, et al. Lymphoproliferative disorders of natural killer cells: report of two cases and review of literature[J]. Int J Clin Exp Pathol, 2020, 13(7): 1755-1759.
|
| [3] |
Tang YT, Wang D, Luo H, et al. Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes[J]. Blood Cancer J, 2017, 7(12): 660. DOI: 10.1038/s41408-017-0021-z.
doi: 10.1038/s41408-017-0021-z
pmid: 29263371
|
| [4] |
夏晶, 陈苏宁, 金正明, 等. 单倍型造血干细胞移植治疗侵袭性NK细胞白血病五例临床观察[J]. 中华血液学杂志, 2021, 42(7): 591-593. DOI: 10.3760/cma.j.issn.0253-2727.2021.07.010.
doi: 10.3760/cma.j.issn.0253-2727.2021.07.010
|
| [5] |
Magnano L, Rivero A, Matutes E. Large granular lymphocytic leukemia: current state of diagnosis, pathogenesis and treatment[J]. Curr Oncol Rep, 2022, 24(5): 633-644. DOI: 10.1007/s11912-021-01159-y.
doi: 10.1007/s11912-021-01159-y
|
| [6] |
Fujimoto A, Ishida F, Izutsu K, et al. Allogeneic stem cell trans-plantation for patients with aggressive NK-cell leukemia[J]. Bone Marrow Transplant, 2021, 56(2): 347-356. DOI: 10.1038/s41409-020-01009-8.
doi: 10.1038/s41409-020-01009-8
|
| [7] |
刘梅, 张瑞, 毛亚菲, 等. 侵袭性NK细胞白血病的实验室特征及诊疗进展[J]. 河北医药, 2022, 44(6): 933-937. DOI: 10.3969/j.issn.1002-7386.2022.06.033.
doi: 10.3969/j.issn.1002-7386.2022.06.033
|
| [8] |
Li C, Tian Y, Wang J, et al. Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia[J]. Transl Res, 2014, 163(6): 565-577. DOI: 10.1016/j.trsl.2014.01.010.
doi: 10.1016/j.trsl.2014.01.010
pmid: 24524877
|
| [9] |
Björkström NK, Riese P, Heuts F, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education[J]. Blood, 2010, 116(19): 3853-3864. DOI: 10.1182/blood-2010-04-281675.
doi: 10.1182/blood-2010-04-281675
pmid: 20696944
|
| [10] |
El Hussein S, Patel KP, Fang H, et al. Genomic and immunophe-notypic landscape of aggressive NK-cell leukemia[J]. Am J Surg Pathol, 2020, 44(9): 1235-1243. DOI: 10.1097/PAS.0000000000001518.
doi: 10.1097/PAS.0000000000001518
pmid: 32590457
|
| [11] |
Bárcena P, Jara-Acevedo M, Tabernero MD, et al. Phenotypic profile of expanded NK cells in chronic lymphoproliferative diso-rders: a surrogate marker for NK-cell clonality[J]. Oncotarget, 2015, 6(40): 42938-42951. DOI: 10.18632/oncotarget.5480.
doi: 10.18632/oncotarget.5480
pmid: 26556869
|
| [12] |
钱文斯, 沈琳, 乌丽盼·甫拉提, 等. 侵袭性NK细胞白血病22例临床特征和预后分析[J]. 中华血液学杂志, 2022, 43(5): 424-426. DOI: 10.3760/cma.j.issn.0253-2727.2022.05.013.
doi: 10.3760/cma.j.issn.0253-2727.2022.05.013
|
| [13] |
Peng XH, Zhang LS, Li LJ. Aggressive natural killer cell leukemia with skin manifestation associated with hemophagocytic lympho-histiocytosis: a case report[J]. World J Clin Cases, 2021, 9(34): 10708-10714. DOI: 10.12998/wjcc.v9.i34.10708.
doi: 10.12998/wjcc.v9.i34.10708
|
